EyePoint (EYPT) Inventory (2018 - 2026)
EyePoint (EYPT) posted Inventory of $1.2 million for Q1 2026, down 31.05% sequentially from $1.8 million in Q4 2025, and down 41.29% YoY from $2.1 million in Q1 2025.
EyePoint (EYPT) Inventory (2018 - 2026) Analysis & Trends
EyePoint has reported Inventory for 9 years, with the latest figure at $1.2 million in Q1 2026.
- Quarterly Inventory fell 41.29% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 41.29% YoY) and the FY2025 annual result came in at $1.8 million, down 21.34% from the prior year.
- Inventory fell to $1.2 million in Q1 2026 per EYPT's latest filing, from $1.8 million in the prior quarter.
- Over five years, Inventory peaked at $4.6 million in Q3 2023 and troughed at $1.2 million in Q1 2026.
- A 5-year average of $3.1 million and a median of $3.3 million in 2022 frame the typical range for Inventory.
- The sharpest annual moves came in 2023 and 2025: Inventory soared 35.34% in 2023, then plunged 49.99% in 2025.
- Over 5 years, Inventory stood at $2.9 million in 2022, then surged by 35.34% to $3.9 million in 2023, then plunged by 40.99% to $2.3 million in 2024, then retreated by 21.34% to $1.8 million in 2025, then slumped by 31.05% to $1.2 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $1.2 million, $1.8 million, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 | 1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.88 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 2.68 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 2.31 Mn |
| Sep 30, 2024 | 2.81 Mn |
| Jun 30, 2024 | 3.67 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 3.91 Mn |
| Sep 30, 2023 | 4.58 Mn |
| Jun 30, 2023 | 4.26 Mn |
| Mar 31, 2023 | 4.07 Mn |
| Dec 31, 2022 | 2.89 Mn |
| Sep 30, 2022 | 3.53 Mn |
| Jun 30, 2022 | 3.25 Mn |
| Mar 31, 2022 | 3.34 Mn |
| Dec 31, 2021 | 3.62 Mn |
| Sep 30, 2021 | 4.57 Mn |